Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report)’s share price was down 3.8% on Wednesday . The stock traded as low as $0.45 and last traded at $0.45. Approximately 214 shares traded hands during trading, a decline of 88% from the average daily volume of 1,835 shares. The stock had previously closed at $0.47.
Zelira Therapeutics Price Performance
The company’s 50-day moving average is $0.49 and its 200-day moving average is $0.43.
Zelira Therapeutics Company Profile
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Read More
- Five stocks we like better than Zelira Therapeutics
- 5 discounted opportunities for dividend growth investors
- Tesla Investors Continue to Profit From the Trump Trade
- What Do S&P 500 Stocks Tell Investors About the Market?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Stock Splits, Do They Really Impact Investors?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
